Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms

The high probability (13%) of women developing breast cancer in their lifetimes in America is exacerbated by the emergence of multidrug resistance after exposure to first-line chemotherapeutic agents. Permeation glycoprotein (P-gp)-mediated drug efflux is widely recognized as the major driver of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Famta, Paras, Shah, Saurabh, Chatterjee, Essha, Singh, Hoshiyar, Dey, Biswajit, Guru, Santosh Kumar, Singh, Shashi Bala, Srivastava, Saurabh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663938/
https://www.ncbi.nlm.nih.gov/pubmed/34909680
http://dx.doi.org/10.1016/j.crphar.2021.100054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663938/
https://www.ncbi.nlm.nih.gov/pubmed/34909680
http://dx.doi.org/10.1016/j.crphar.2021.100054

Ejemplares similares